Similarly, NLGN3 overexpression also recovered the expression of the stem cell marker, CD133, in both mRNA and surface protein levels, suggesting the involvement of NLGN3 in regulating GBM-CSCs properties (Fig. 3D, E). The gene discussed is NLGN3; the disease is glioblastoma.